Phase 2 Study of Novel Partial Tumor Irradiation for Sparing Peri-Tumoral Immune Microenvironment.

被引：0
|
作者：
Tubin, S. [1 ]
Khan, M. K. [2 ]
Salerno, G. [3 ]
Mourad, W. F. [4 ]
Yan, W. [5 ]
Jeremic, B. [6 ,7 ,8 ]
机构：
[1] Landeskrankenhaus Klagenfurt, Strahlentherapie & Radioonkol, Klagenfurt, Austria
[2] Emory Univ, Sch Med, Winship Canc Ctr, Dept Radiat Oncol, Atlanta, GA 30322 USA
[3] Univ Roma La Sapienza, Osped St Andrea, Dept Neurosci Mental Hlth & Sensory Organs, Dept Clin & Mol Med, Rome, RM, Italy
[4] Univ Kentucky, Dept Radiat Med, Markey Canc Ctr, Lexington, KY USA
[5] Thomas Jefferson Univ Philadelphia, Dept Radiat Oncol, Philadelphia, PA USA
[6] Res Inst Clin Med, Tbilisi, Georgia
[7] BioIRC R&D Ctr Biomed Res, Kragujevac, Serbia
[8] Dept Radiat Oncol, Tbilisi, Georgia
来源：
RADIOTHERAPY AND ONCOLOGY | 2020年 / 152卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PH-0282
引用
收藏
页码：S142 / S143
页数：2
相关论文
共 50 条
  • [21] HFB9-2: A novel Gal-9 neutralizing antibody to reverse immune suppression in the tumor microenvironment
    Margall, Germain
    Pacherie, Rachel
    Prigent, Julie
    Zhou, He
    Adrian, Francisco
    Schweizer, Liang
    Raue, Andreas
    Kumar, Roshan
    Beltraminelli, Nicola
    Beq, Stephanie
    CANCER RESEARCH, 2020, 80 (16)
  • [22] CD2 Is a Novel Immune-Related Prognostic Biomarker of Invasive Breast Carcinoma That Modulates the Tumor Microenvironment
    Chen, Yanzhu
    Meng, Zhishang
    Zhang, Lin
    Liu, Feng
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [23] A Novel Antagonist of the Immune Checkpoint Protein Adenosine A2a Receptor Restores Tumor-Infiltrating Lymphocyte Activity in the Context of the Tumor Microenvironment
    Mediavilla-Varela, Melanie
    Castro, Julio
    Chiappori, Alberto
    Noyes, David
    Hernandez, Dalia C.
    Allard, Bertrand
    Stagg, John
    Antonia, Scott J.
    NEOPLASIA, 2017, 19 (07): : 530 - 536
  • [24] Positron emission tomography/computed tomography using 2-deoxy-2-fluoro-18-fluoro-D-glucose peri-tumoral halo uptake layer method outperforms magnetic resonance imaging and ultrasound methods in tumor size measurement of breast cancer
    Wu, Yingzhe
    Lu, Yuezhong
    Xu, Chentao
    Lin, Bin
    ONCOLOGY LETTERS, 2020, 19 (06) : 3881 - 3888
  • [25] A novel hypoxic tumor microenvironment signature for predicting the survival, progression, immune responsiveness and chemoresistance of glioblastoma: a multi-omic study
    Wang, Zihao
    Gao, Lu
    Guo, Xiaopeng
    Wang, Yaning
    Wang, Yu
    Ma, Wenbin
    Guo, Yi
    Xing, Bing
    AGING-US, 2020, 12 (17): : 17038 - 17061
  • [26] Impact of Anti-HER2 Treatments Combined With Atezolizumab on the Tumor Immune Microenvironment in Early or Metastatic Breast Cancer: Results From a Phase Ib Study
    Hamilton, Erika P.
    Kaklamani, Virginia
    Falkson, Carla
    Vidal, Gregory A.
    Ward, Patrick J.
    Patre, Monika
    Chui, Stephen Y.
    Rotmensch, Jacob
    Gupta, Kushagra
    Molinero, Luciana
    Li, Yijin
    Emens, Leisha A.
    CLINICAL BREAST CANCER, 2021, 21 (06) : 539 - 551
  • [27] COX-2-related tumor immune microenvironment in non-small cell lung cancer: a novel signature to predict hot and cold tumor
    Wang, Tiangong
    Luo, Ying
    Zhang, Qi
    Shen, Yanping
    Peng, Min
    Huang, Ping
    Zhou, Zijian
    Wu, Xinyi
    Chen, Ke
    JOURNAL OF THORACIC DISEASE, 2022, 14 (03) : 729 - 740
  • [28] ATP2C2 as a novel immune-related marker that defines the tumor microenvironment in triple-negative breast cancer
    Zhao, Mingyuan
    Zhang, Qilong
    Song, Zichen
    Lei, Huan
    Li, Jing
    Peng, Fang
    Lin, Shuangyan
    TRANSLATIONAL CANCER RESEARCH, 2023, 12 (07) : 1802 - 1815
  • [29] The tumor immune microenvironment and HER2 landscape of high-risk ductal carcinoma in situ: The DEFENSE study
    Glencer, Alexa
    Borowsky, Alexander
    Mori, Hidetoshi
    Campbell, Michael
    Harismendy, Olivier
    Stein, Janet
    Ghule, Prachi
    Evans, Mark
    West, Robert
    Hirst, Gillian
    Schindler, Nicole
    Miller, Phoebe
    Lee, Kyra
    Weaver, Donald
    Esserman, Laura
    CANCER RESEARCH, 2022, 82 (04)
  • [30] ARGX-111 shows activity in MET-amplified patients in a phase-I study and in preclinical models of myeloid-derived suppressor cell (MDSC) depletion in the tumor microenvironment.
    Rolfo, Christian Diego
    Aftimos, Philippe Georges
    Pallandre, Jean-Rene
    Morello, Virginia
    Bouard, Adeline
    Cazzanti, Manuela
    Barthelemy, Philippe
    Rottey, Sylvie
    Awada, Ahmad
    Hanssens, Valerie
    De Jonge, Natalie
    Van Rompaey, Luc
    Fung, Samson Sau-Sing
    Michieli, Paolo
    Borg, Christophe
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345